This trial is testing a new cancer screening test to see if it is safe and effective. 20,000 people will be enrolled over 18 months, and will be followed for 3 years.
- Early Detection of Cancer
8 Primary · 7 Secondary · Reporting Duration: Up to 3 Years
Awards & Highlights
1 Treatment Group
Participants 50 years of age or older
1 of 1
20000 Total Participants · 1 Treatment Group
Primary Treatment: Multi-Cancer Early Detection Test · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
|Did not meet criteria||100.0%|
Why did patients apply to this trial?
- "Recent Upper endoscope detected precancerous colon polyp"
How many prior treatments have patients received?
Frequently Asked Questions
Is enrollment for this research endeavor still open?
"Per clinicaltrials.gov, this experiment is actively recruiting patients for participation. Initially posted on December 8th 2021, the study has since been updated to current standards as of August 4th 2022." - Anonymous Online Contributor
How many participants are enrolled in the current research endeavor?
"An aggregate of 20,000 participants with the appropriate characteristics are needed to partake in this trial. Individuals can join from Texas Oncology - Fort Worth based in Fort Worth California and Sutter Health located at Auburn Maryland." - Anonymous Online Contributor
At how many locations is this clinical trial being managed?
"This clinical trial is enlisting patients from 32 different medical facilities, with the most prominent being Texas Oncology - Fort Worth in Fort Worth, California, Sutter Health in Auburn and Maryland Oncology Hematologyin Annapolis." - Anonymous Online Contributor